Table 2.
panel A: Prevalence of LPV, JCV and BKV DNA sequences in peripheral blood from HIV+ patients, divided on the basis of the neurological disease.
Panel B: Prevalence of LPV, JCV and BKV DNA sequences in peripheral blood from healthy subjects, divided into ages groups.
| A | |||||
|---|---|---|---|---|---|
| HIV+ PATIENTS |
|||||
| PML | NDLE | OND | NND | TOTAL | |
| LPV | 1/11 (9.1%) |
2/16 (12.5%) |
0/11 | 3/45# (6.7%) |
6/83 (7.2%) |
| JCV | 2/11 (18.2%) |
2/16* (12.5%) |
3/11 (27.2%) |
6/45* (13.3%) |
13/83 (15.7%) |
| BKV | 1/7 (14.2%) |
3/11* (27.3%) |
2/5 (40%) |
11/45*# (24.4%) |
17/68 (25%) |
| TOTAL | 4/11 (36.4%) |
7/16 (43.7%) |
5/11 (45.4%) |
20/45 (44.4%) |
36/83 (43.4%) |
| B | ||||||
|---|---|---|---|---|---|---|
| HEALTHY SUBJECTS |
||||||
| < 9 | 9 – 19 | 20 – 49 | 50 – 69 | > 70 | TOTAL | |
| LPV | 1/22 (4.5%) |
0/17 | 1/26 (3.8%) |
1/19 (5.2%) |
2/21 (9.5%) |
5/105 (4.7%) |
| JCV | 0/22 | 0/17 | 0/26 | 0/19 | 2/21 (9.5%) |
2/105 (1.9%) |
| BKV | 2/22 (9.1%) |
1/17 (5.8%) |
3/26 (11.5%) |
3/19 (15.7%) |
3/21 (14.3%) |
12/105 (11.4%) |
| TOTAL | 3/22 (13.6%) |
1/17 (5.8%) |
4/26 (15.38%) |
4/19 (21.05%) |
7/21 (33.3%) |
19/105 (18.1%) |
*
: one patient had a double infection JCV+BKV;
#
: two patients had a double infection LPV+BKV